Edition:
United States

Prima BioMed Ltd (PRR.AX)

PRR.AX on Australia Stock Exchange

0.04AUD
7 Dec 2016
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.04
Open
$0.04
Day's High
$0.04
Day's Low
$0.04
Volume
364,228
Avg. Vol
1,087,322
52-wk High
$0.06
52-wk Low
$0.03

PRR.AX

Chart for PRR.AX

About

Prima BioMed Ltd is a biotechnology company. The Company is engaged in research, development and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment. Its core technologies are based on the Lymphocyte-activa... (more)
No analyst recommendations are available for PRR.AX.

Overall

Beta: 0.88
Market Cap(Mil.): $74.58
Shares Outstanding(Mil.): 2,071.54
Dividend: --
Yield (%): --

Financials

  PRR.AX Industry Sector
P/E (TTM): -- 42.12 30.77
EPS (TTM): -0.03 -- --
ROI: -183.24 -0.81 15.23
ROE: -206.69 -1.52 16.56

BRIEF-Prima signs MOU with WuXi

* Mou was signed to form a strategic biologics development and manufacturing partnership Source text for Eikon: Further company coverage:

Nov 22 2016

Earnings vs. Estimates